MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001465/mwtabprimaryOK200NMRGraft Versus Host Diseasehttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001465Treatment Protocol:allogenicTreatment Protocol:naiveTreatment Protocol:syngenicSpleenNMR data.MetabolomicsWorkbenchMetabolomicsMus MusculusUniversity of KentuckyAXP-1' 13C-A_1Itaconate-5a_1AXP-8_1NAD-N2_1AXP-8_2NAD+-N1'_1NAD+-N1'_2For_1bOH-butyrate_1bOH-butyrate_2pyruvate-3_1Succinate-2,3_1Lac-2 13C-B_14Lac-2 13C-B_13Lac-2 13C-B_12Lac-2 13C-B_11Lac-2 13C-B_10Phe-2,6_2Phe-2,6_1Thr_1Thr_2Val-B_2Val-B_1Lac13C-B_7Lac13C-B_8Tyr-3,5_1GSSG-12_3bGlc_1Tyr-3,5_2GSSG-12_4bGlc_2GSSG-12_1GSSG-12_2Ala-3_1Ala-3_2Phe-3,5_3Lac13C-B_5Lac-2 13C-B_7Phe-3,5_2Lac13C-B_6Lac-2 13C-B_6Phe-3,5_1Lac13C-B_3Lac-2 13C-B_9Lac13C-B_4Lac-2 13C-B_8Lac13C-B_1Lac13C-B_2Trp-4_1Trp-4_2m-Ins-1,3_1m-Ins-2?_2m-Ins-2?_1Ile_2Ile_1m-Ins-1,3_4m-Ins-1,3_3Nicotin-5_1Tyr-2,6_1Tyr-2,6_2m-Ins-1,3_2Lac-2 13C-B_1Lac-2 13C-B_3Lac-2 13C-B_2Lac-2 13C-B_5Lac-2 13C-B_4Ala13C-A_4Ala13C-A_5Ala13C-A_6Ala13C-A_7Ala13C-A_1Ala13C-A_2Ala13C-A_3Gln+Glu-2_10NADP-N2_1AXP-1' 13C-B_1Tau-1 (SCH2)_3Tau-1 (SCH2)_2Tau-1 (SCH2)_1aGlc 13C-B_1Cys-3-GSH_4Gly_1Cys-3-GSH_3Cys-3-GSH_2Cys-3-GSH_1AXP-1'_2AXP-1'_1AXP-1'_4AXP-1'_3CXP-6_1CXP-6_2m-Ins-2?_3Glu-4_3Ser-2_4Glu-4_2Ser-2_5Glu-4_1Ser-2_2Ser-2_3Ser-2_8Glu-4_7Ser-2_9Glu-4_6Glu-4_5Ser-2_6Ser-2_7Glu-4_4Me-His A_1Ser-2_1NAD-N6_1NAD-N6_2aGlc 13C-A_1Glu-4_9Glu-4_8Tau-2 (NCH2)_3Tau-2 (NCH2)_2Tau-2 (NCH2)_1Lac-3_1Lac-3_2Glu-3-a_15Glu-3-a_14Glu-3-a_16Glu-3-a_11Glu-3-a_10Glu-3-a_13Glu-3-a_12Pro-5 A_1Pro-5 A_2Pro-5 A_3Pro-5 A_4Me-His B_1Pro-5 A_5Pro-5 A_6Pro-5 A_7Pro-5 A_8Creat_1Ala13C-B_3bGlc 13C-A_3Gln-4_8Ala13C-B_4bGlc 13C-A_2Gln-4_7Ala13C-B_5Ala13C-B_6bGlc 13C-A_4Gln-4_9Ala13C-B_1bGlc 13C-A_1NAD+-A1'_2Glu-4_11Ala13C-B_2NAD+-A1'_1Glu-4_10Gln-4_2Gln-4_1Gln-4_4Gln-4_3Gln-4_6Gln-4_5GSH+GSSG-4_14GSH+GSSG-4_15Glycogen_2GSH+GSSG-4_16Glycogen_1GSH+GSSG-4_10P-Cho A_1GSH+GSSG-4_11GSH+GSSG-4_12GSH+GSSG-4_13Fum_1Asp-3a_1AXP-2_5AXP-2_1Gln-4_12AXP-2_2Gln-4_13AXP-2_3Lac13C-A_8Gln-4_14AXP-2_4Lac13C-A_9Gln-4_10Gln-4_11Asp-3a_4Asp-3a_2Asp-3a_3GSH+GSSG-3_3Glu-3-a_6GSH+GSSG-3_2Glu-3-a_5NAD+-N1' 13C-B_1Glu-3-a_8GSH+GSSG-3_4Glu-3-a_7Glu-3-a_9GSH+GSSG-3_1UXP-6_1Lac13C-A_6UXP-6_2Lac13C-A_7UXP-6_3Lac13C-A_4Lac13C-A_5DSS_1Lac13C-A_2P-Cho B_8Lac13C-A_3P-Cho B_9Lac13C-A_1NADP-N6_1P-Cho B_4NADP-N6_2P-Cho B_5P-Cho B_6P-Cho B_7P-Cho B_1P-Cho B_2P-Cho B_3aGlc_1aGlc_2Asp-3b_3Asp-3b_4Asp-3b_1Asp-3b_2Glu-3-a_2Glu-3-a_1Glu-3-a_4Glu-3-a_3GSH+GSSG-4_2Lac-2_3GSH+GSSG-4_1Lac-2_2GSH+GSSG-4_4Lac-2_1Gln+Glu-2_9GSH+GSSG-4_3Gln+Glu-2_8GSH+GSSG-4_6Gln+Glu-2_7GSH+GSSG-4_5Gln+Glu-2_6GSH+GSSG-4_8Gln+Glu-2_5GSH+GSSG-4_7Gln+Glu-2_4Gln+Glu-2_3Gln+Glu-2_2Gln+Glu-2_1Lac-2_5Lac-2_4UXP-5_2UXP-5_3UXP-5_4Ace-2_1UXP-1'_1UXP-1'_2GSH+GSSG-4_9UXP-5_1Pulmonary Injury, E-Cigarette or Vaping Product Use-Associated Lung Injury, Injury, Lung, Transplantation, Pulmonary Injuries, Metabonomic, Lung Injuries, Chronic Lung Injury, Metabonomics, EVALI, Lung Injury, Cell, Injuries, E Cigarette Use Associated Lung Injury, Vaping Product Use Associated Lung Injury, lien., Vaping Product Use-Associated Lung Injury, Chronic, E-Cigarette Use-Associated Lung Injury, Chronic Lung Injuries, E Cigarette or Vaping Product Use Associated Lung Injury, Metabolomic, Pulmonary, EVALIsfalseMetabolomics of lung injury after allogeneic hematopoietic cell transplantation - Spleen NMR 1DST00146510090